Compare Edge Therapeutics vs FORMAC Pharmaceuticals N.V.
Customers evaluate the quality of Edge Therapeutics's products using the following success metrics.
Overview
Edge Therapeutics is based in United States
Edge Therapeutics is a clinical-stage biotechnology company that discovers, develops and seeks to commercialize hospital-based therapies capable of transforming treatment paradigms in the management of acute, life-threatening neurological conditions. EG-1962, its lead product candidate, has the potential to fundamentally improve patient outcomes and transform the management of aneurysmal subarachnoid hemorrhage, or aSAH, which is bleeding around the brain due to a ruptured brain aneurysm. EG-1964, its second product candidate, is being evaluated as a potential prophylactic treatment in the management of chronic subdural hematoma (cSDH), to prevent recurrent bleeding on the surface of the brain.
FORMAC Pharmaceuticals N.V. is 17 yrs old and is based in Belgium.
FORMAC is a pharmaceutical R&D company engaged in drug delivery and development. The firm aims to increase pharmaceutical R&D productivity and product value by enhancing the performance of (pre)clinical drug candidates and marketed drugs.
Demo Video
Leadership
Albert N Marchio (Chief Operating Officer)
Laurens G. Theunis (Chief Executive Officer)
Funding
Investors
Franklin Advisers, New Leaf Venture Partners
Vlaams Innovatiefonds, Gemma Frisius Fonds
Product
Benefits
Products
Customers
Known Partners
Why They Buy
Information not available because Edge Therapeutics has not claimed their profile.
Work for Edge Therapeutics? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Edge Therapeutics?
Claim your profile now.
Information not available because FORMAC Pharmaceuticals N.V. has not claimed their profile.
Work for FORMAC Pharmaceuticals N.V.? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for FORMAC Pharmaceuticals N.V.?
Claim your profile now.